Zytiga – pharmaceutical daily

August 15, 2019 Off

Trovagene with new data from testing onvansertib with Zytiga for certain prostate cancer

Trovagene will present new clinical data from its Phase 2 trial of onvansertib, in combination with Zytiga (abiraterone acetate)/prednisone, in…

January 23, 2019 Off

Trovagene expands the use of Onvansertib

By Dino Mustafić

Trovagene has expanded the use of Onvansertib to enable it for combination therapies with anti-androgen drugs, like Zytiga, Xtandi and Erledea to treat castrate-resistant prostate cancer.

February 16, 2018 Off

Canada allows combination of Janssen’s Zytiga with ADT in to treat certain prostate cancer (mHSPC)

By Dino Mustafić

Johnson & Johnson’s Janssen has welcomed the news from Health Canada as it got approval to use Zytiga combined with prednisone…